Christina (Tina) P./LinkedIn
Jun 21, 2026, 14:38
Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Bleeding Risks and Blood Thinners: APS Awareness Day 21
Blood thinners (also called anticoagulants) are medicines that prevent blood clots.
They’re often used in conditions like Antiphospholipid Syndrome (APS) to reduce the risk of strokes, deep vein thrombosis (DVT), and other clot-related issues.
Blood thinners save lives by preventing dangerous clots — but they must be taken carefully to avoid serious bleeding.
Knowing the risks helps you stay safe and prepared.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales